Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Identification and validation of an interaction between the E3 ubiquitin ligase WWP1 and the Transcriptional Co-Activator WBP2 in the human heart. [PDF]
Arnold ME +4 more
europepmc +1 more source
E3 ubiquitin ligase SKP2 limits autophagosome formation during <i>Staphylococcus aureus</i> infection. [PDF]
Singh AK +11 more
europepmc +1 more source
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78. [PDF]
Chatterjee M +6 more
europepmc +1 more source
The E3 ubiquitin ligase FBXL18 stabilizes BST2 to promote inflammation in RABV-infected astrocytes. [PDF]
Wang J +15 more
europepmc +1 more source
Regulation of host immunity by a novel Legionella pneumophila E3 ubiquitin ligase. [PDF]
Liu S +10 more
europepmc +1 more source
The E3 ubiquitin ligase mechanism specifying target-directed microRNA degradation
Farnung J +7 more
europepmc +1 more source
Molecular determinants underlying substrate receptor specificity of human CRL4B E3 ubiquitin ligase
Mohamed WI +7 more
europepmc +1 more source
LRRC58 defines an E3 ubiquitin ligase complex sensitive to cysteine abundance
Ramage DE +14 more
europepmc +1 more source

